Raloxifene
At a glance
- Drug Originator Eli Lilly and Company
- Drug Licenced by Chugai Pharmaceutical; Daiichi Sankyo Europe; Pensa Pharma; Pharmaserve SA - Eli Lilly (JV); Prasco Laboratories; Takeda; Terapia
- Drug Class Antineoplastics; Calcium regulators; Osteoporosis therapies; Small molecules; Stilbenes
- Mechanism of Action Selective estrogen receptor modulators
- USA Patent Applicants LILLY
- USA Patents 26
- NDAs 1
- Patent Applications 3,781
Table of Contents
Disclaimer